Longitudinal Observation of Insulin Use and Glucose Sensor Metrics in Pregnant Women with Type 1 Diabetes Using Continuous Glucose Monitors and Insulin Pumps: The LOIS-P Study
Authors:
- Grenye O'MAlleyGOGrenye O'MAlley
- Basak OzaslanBOBasak Ozaslan
- Carol J. LevyCLCarol J. Levy
- Kristin CastorinoKCKristin Castorino
- Donna DesjardinsDDDonna Desjardins
- Camilla LevisterCLCamilla Levister
- Shelly K McCrady-SpitzerSMShelly K McCrady-Spitzer
- Mei Mei ChurchMCMei Mei Church
- Ravinder Jeet KaurRKRavinder Jeet Kaur
- Corey ReidCRCorey Reid
- Walter K. KremersWKWalter K. Kremers
- Francis J. DoyleFDFrancis J. Doyle
- 25 November 2021
- journal article
- research article
- Published by SAGE Publications in Diabetes Technology & Therapeutics
- Vol. 23 (12) , 807-817
Abstract
Background: Suboptimal glycemic control is associated with maternal and neonatal morbidity and mortality in pregnancy complicated by type 1 diabetes (T1D). Prospective analysis of continuous glucose monitoring (CGM) metrics, insulin pump settings, and insulin delivery can better characterize the changes in glycemic levels and insulin use throughout pregnancy with T1D. Materials and Methods: Prescribed parameters, insulin delivery, carbohydrate intake, and CGM data for 25 pregnant women with T1D from three U.S. sites were collected. Participants enrolled before 17 weeks gestation and used personal insulin pumps and study CGM. Mean daily total, basal, and bolus insulin doses (units/kg), CGM time in range (TIR: 63–140 mg/dL), and pump-entered carbohydrates were analyzed for every 2-week gestational interval. Linear mixed-effects regression models were used to evaluate changes across gestational ages compared to 12–14 weeks. Results: Basal insulin was higher during weeks 6–12 and 24–40. Daily bolus and total insulin were higher during weeks 20–40. Pump parameters were adjusted to intensify insulin therapy from 22 weeks onward. Average TIR across pregnancy was 59% ± 14%. Between 18 and 30 weeks, TIR was significantly lower, and time above range was significantly higher compared to the reference biweek. Time below target was lower between 22 and 34 weeks. Seven participants achieved >70% recommended TIR for pregnancy. Participants with maternal complications or infant neonatal intensive care unit admissions had lower TIR. Conclusion: While insulin dosing changed significantly with advancing gestation, most participants did not achieve >70% TIR. Customized anticipatory pump setting adjustments and automated systems aimed toward the designated TIR are needed to improve outcomes for this population. NCT03761615Keywords
This publication has 28 references indexed in Scilit:
- Hypoglycaemia during pregnancy in women with Type 1 diabetesDiabetic Medicine, 2012
- Optimal Glycemic Control, Pre-eclampsia, and Gestational Hypertension in Women With Type 1 Diabetes in the Diabetes and Pre-eclampsia Intervention TrialDiabetes Care, 2011
- Insulin requirements throughout pregnancy in women with type 1 diabetes mellitus: three changes of directionDiabetologia, 2009
- Obstetric and Perinatal Outcomes in Type 1 Diabetic PregnanciesDiabetes Care, 2009
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2009
- Macrosomia in well controlled CSII treated Type I diabetic pregnancyGynecological Endocrinology, 2008
- Perinatal mortality and congenital anomalies in babies of women with type 1 or type 2 diabetes in England, Wales, and Northern Ireland: population based studyBMJ, 2006
- Risk of complications of pregnancy in women with type 1 diabetes: nationwide prospective study in the NetherlandsBMJ, 2004
- Nutrition During Pregnancy: Part I, Weight Gain; Part II, Nutrient SupplementsJAMA, 1991
- Effect of euglycemia on the outcome of pregnancy in insulin-dependent diabetic women as compared with normal control subjectsThe American Journal of Medicine, 1981